The Lancet
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
駆出率低下型心不全(GOAL‑HF1)における経口グレリン受容体作動薬AC01の安全性、薬物動態および探索的有効性:ランダム化二重盲検プラセボ対照第Ⅰb/Ⅱa相試験